ChemoCentryx
CCXI
#3560
Rank
NZ$6.46 B
Marketcap
NZ$89.84
Share price
0.00%
Change (1 day)
34.92%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -NZ$0.2 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are NZ$37.2 Million. In 2021 the company made an earning of -NZ$0.23 Billion a decrease over its 2020 earnings that were of -NZ$91.09 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.2 Billion-12.85%
2021 -NZ$0.23 Billion144.84%
2020 -NZ$91.09 Million-1.18%
2019 -NZ$92.18 Million45.17%
2018 -NZ$63.5 Million-305.69%
2017 NZ$30.86 M-144.7%
2016 -NZ$69.06 Million-15.52%
2015 -NZ$81.75 Million0.85%
2014 -NZ$81.06 Million21.47%
2013 -NZ$66.73 Million-1.24%
2012 -NZ$67.56 Million906.88%
2011 -NZ$6.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$3.29 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.86 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.10 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
NZ$13.88 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.98 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.24 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.48 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-1,456.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$39.89 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA